Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

• Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative
• The two companies will co-establish a NewCo in Spain to serve as a strategic hub in Europe, accelerating global expansion of the initiative
• Localization of Seegene's syndromic real-time PCR product development and manufacturing will bring diagnostic products specifically tailored to the needs of the local market

SEOUL, South Korea, Oct. 8, 2024 /PRNewswire/ -- Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today the finalization of a partnership agreement with Werfen, a worldwide leader in specialized diagnostics, on the technology-sharing initiative. Under the agreement, Seegene and Werfen will set up a NewCo in Spain, Werfen-Seegene, upon the conclusion of mandatory government approvals anticipated by the first half of 2025.